Antibacterial Mechanism of Nanosilvers Yingshan DongXuesong Sun Nanodrugs (ATY Lau, Section Editor) 23 November 2019 Pages: 401 - 409
The Mechanism of Nano-drug Delivery Siying LiHongda WangYuping Shan Nanodrugs (ATY Lau, Section Editor) 05 December 2019 Pages: 410 - 420
The Diagnostic and Therapeutic Potential of the Epigenetic Modifications of Lung Cancer–Related Genes Shengqing LiHai Zou Epigenetics (ATY Lau, Section Editor) 20 November 2019 Pages: 421 - 428
Usnic Acid Derivatives as Cytotoxic Agents Against Cancer Cells and the Mechanisms of Their Activity Beata Guzow-KrzemińskaKatarzyna GuzowAnna Herman-Antosiewicz Natural Products: From Chemistry to Pharmacology (C Ho, Section Editor) Open access 16 November 2019 Pages: 429 - 439
Synthesis, Structure Characterization, and Biological Evaluation of 3-Amino-5-(5-Oxo-5H-Benzo[a]Phenothiazin-6-Ylamino) Benzoic Acid Derivatives via Molecular Docking, Cytotoxicity, and Antioxidant Studies Palanichamy Santhosh KumarDhanaraj PremnathSamuel Vasanthkumar Pharmacometabolomics and Toxicometabolmics (C Chen, Section Editor) 10 December 2019 Pages: 440 - 459
A Three-dimensional and Dynamic (3DD) Cell Culture System for Evaluation of Pharmacokinetics, Safety and Efficacy of Anti-cancer Drugs Tanaya R. VaidyaYesenia L. FrancoSihem Ait-Oudhia Pharmacometrics and Quantitative System Pharmacology (A Chakraborty and S Polak, Section Editors) Open access 28 August 2019 Pages: 460 - 467
Using Zebrafish to Investigate Interactions Between Xenobiotics and Microbiota Tara R. CatronShaza GaballahTamara Tal Microbiome (A Patterson, Section Editor) 15 November 2019 Pages: 468 - 480
Microbiome Is a Functional Modifier of P450 Drug Metabolism Joseph L. DempseyJulia Yue Cui Microbiome (A Patterson, Section Editor) 19 October 2019 Pages: 481 - 490
The Human Gut Microbiome’s Influence on Arsenic Toxicity Michael CoryellBarbara A. RoggenbeckSeth T. Walk Microbiome (A Patterson, Section Editor) Open access 25 November 2019 Pages: 491 - 504
